Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hazem A. Al-Bustany
Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase Α Inhibitors
ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY
Related publications
Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Phosphatidylinositol-3-Kinase Pathway
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Regulation of the P85/P110α Phosphatidylinositol 3′-Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Association of P21ras With Phosphatidylinositol 3-Kinase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Levels of Target Activation Predict Antifibrotic Responses to Tyrosine Kinase Inhibitors
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Phosphatidylinositol 3-Kinase Signaling Determines Kidney Size
Journal of Clinical Investigation
Medicine